Jagiellonian University Repository

Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

pcg.skipToMenu

Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

Bibliographic description

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)